TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Takanori Yokota, MD, PhD
Professor, Neurology and Neurological Science at Tokyo Medical and Dental University

Profile

Takanori Yokota, MD, PhD graduated from Tokyo Medical and Dental University in 1990.

He studied as a research fellow in Dale E Bredesen's lab at Burham Institute (CA, USA) in 1998-1999 and at Buck Center for Aging Research (CA, USA) in 1999-2000.

He is an inventor and founder of RENA Therapeutics for DNA/RNA heteroduplex oligonucleotides. In 2019, he is a president of Nucleic Acides Therapeutics Society of Japan (NATS-J) and board of director of Oligonucleotide Therapeutics Society (OTS).

Takanori Yokota, MD, PhD's Network

Agenda Sessions

  • Systemically Administered DNA/RNA Heteroduplex Oligonucleotides That Can Efficiently Regulate CNS Genes

    , 08:40

Speakers at this event